reports
Transocean Ltd: 1 director
A director at Transocean Ltd bought 2,000,000 shares at 6.010USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
- Martin Huseby Karlsen
Core Molding Technologies Inc: 2 directors
Two Directors at Core Molding Technologies Inc sold 24,283 shares at between 19.716USD and 20.192USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direc...
PDS Biotech Provides Business Update and Reports First Quarter 2024 Fi...
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results Provided Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer Expanded Global Intellectual Property Surrounding Versamune® Platform PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of in...
ExlService Holdings Inc: 1 director
A director at ExlService Holdings Inc sold 45,000 shares at 30.517USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
EXL to participate in upcoming investor conferences
EXL to participate in upcoming investor conferences NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a leading data analytics and digital operations and solutions company, today announced Maurizio Nicolelli, executive vice president, chief financial officer, and John Kristoff, vice president, head investor relations, are expected to participate at the following investor conferences: Needham & Company 19th Annual Technology & Media Conference, Wednesday, May 15, 2024, New York, NY, (presentation at 12:45 pm EDT)Cowen & Company 52nd Annual Technology, ...
Avalo Reports First Quarter 2024 Financial Results and Provides Busine...
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024. “Over the past month we have made considerable progress toward initiating our planned Phase 2 trial of AVTX-009 in hid...
- Sid Rajeev
New Report: Contango Ore's Strategic Gold Mining Acquisition and Its M...
We are excited to share our latest equity research report on Contango Ore, Inc. (CTGO). In this report, we explore CTGO's recent acquisition of HighGold Mining, a move poised to significantly enhance their portfolio. This all-share deal, valued at $37 million, not only adds the high-grade Johnson Tract project in Alaska to CTGO's assets but also positions the company for accelerated growth and cost-effective production.
Moody's Ratings withdraws CSI Compressco's ratings following debt exti...
Moody's Ratings (Moody's) withdrew all of CSI Compressco LP's (Compressco) ratings, including its Caa1 Corporate Family Rating (CFR), Caa1-PD Probability of Default Rating (PDR), and SGL-3 Speculative Grade Liquidity Rating (SGL). The outlook was changed to rating withdrawn from rating under review....
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study E...
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer 30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS≥1); 48% (CPS≥20) Phase 3 registrational trial planned to initiate in 2024 PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious dis...
Quest Resource Holding Corporation Reports First Quarter 2024 Financia...
Quest Resource Holding Corporation Reports First Quarter 2024 Financial Results Double-Digit Growth in Gross Profit Resulting from Business Expansion and Efficiency Gains Significant New Business Wins and Pipeline Growth Reflect Company’s Strong Value Proposition and Momentum Investor Conference Call & Webcast to be held at 5pm ET on Thursday, May 9, 2024 THE COLONY, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest”), a national leader in environmental waste and recycling services, today announced financial results for the first quarter ...
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the Company will participate in two upcoming investor conferences taking place in May 2024. Details are as follows: The Citizens JMP Life Sciences ConferenceEvent: Company presentation and 1:1 meetingsPresentation Da...
DXP Enterprises, Inc. Reports First Quarter 2024 Results
HOUSTON--(BUSINESS WIRE)-- DXP Enterprises, Inc. ("DXP" or the "Company") (NASDAQ: DXPE) today announced financial results for the first quarter ended March 31, 2024. The following are results for the three months ended March 31, 2024, compared to the three months ended March 31, 2023 and December 31, 2023, where appropriate. A reconciliation of the non-GAAP financial measures can be found in the back of this press release. First Quarter 2024 Financial Highlights: Sales increased 1.4 percent sequentially to $412.6 million, compared to $407.0 million for the fourth quarter of 2023 and decr...
Core Molding Technologies to Participate in the EF Hutton Annual Globa...
Core Molding Technologies to Participate in the EF Hutton Annual Global Conference in NYC COLUMBUS, Ohio, May 08, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that David Duvall, President and CEO, and John Zimmer, EVP and CFO, will participate in the EF Hutton ...
- Jay Kornreich
- Richard Anderson
- Sydnie Rohme
- Wedbush Research
GEO GEO GROUP INC. (THE)
LOGN LOGITECH INTERNATIONAL S.A.
WAL WESTERN ALLIANCE BANCORP
SBUX STARBUCKS CORPORATION
RHP RYMAN HOSPITALITY PROPERTIES INC.
PEB PEBBLEBROOK HOTEL TRUST
GPRO GOPRO INC. CLASS A
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
EXLS EXLSERVICE HOLDINGS INC.
EWBC EAST WEST BANCORP INC.
CXW CORECIVIC INC.
CTMX CYTOMX THERAPEUTICS INC.
OSTK OVERSTOCK.COM INC.
HST HOST HOTELS & RESORTS INC.
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
PK PARK HOTELS & RESORTS INC.
CELH CELSIUS HOLDINGS INC.
DNLI DENALI THERAPEUTICS INC
HEAR TURTLE BEACH CORP.
PRPL PURPLE INNOVATION
ARVN ARVINAS HOLDING
LYFT LYFT
GOSS GOSSAMER BIO
RVLV REVOLVE GROUP
IDYA IDEAYA BIOSCIENCES
CRSR CORSAIR GAMING
REAL REALCO
UPST UPSTART HOLDINGS
TWKS THOUGHTWORKS HOLDING
MQ MARQETA INC
JANX JANUX THERAPEUTICS INC
YOU CLEAR SECURE INC
VIGL VIGIL NEUROSCIENCE INC
HR HEALTHCARE TRUST OF AMERICA INC.
BROS DUTCH BROS INC
- Moshe Katri
- Spencer Lebov
Comscore Reports First Quarter 2024 Results
Comscore Reports First Quarter 2024 Results RESTON, Va., May 07, 2024 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the quarter ended March 31, 2024. Q1 2024 Financial Highlights Revenue for the first quarter was $86.8 million compared to $91.6 million in Q1 2023Net loss of $1.1 million compared to $8.7 million in Q1 2023Adjusted EBITDA of $8.1 million compared to $5.2 million in Q1 2023Ma...
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15...
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024 PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the Company will report financial results for the first quarter of 2024 and provide a business update on Wednesday, May 15, 2024, before the market opens. The press release will be available in the Investor Re...
Core Molding Technologies Reports Fiscal 2024 First Quarter Results
Core Molding Technologies Reports Fiscal 2024 First Quarter Results COLUMBUS, Ohio, May 07, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today reports financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights Total net sales of ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.